SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole

Summary

The purpose of this study is to determine how safe, effective, and well tolerated a new investigational antifungal drug, SUBA-itraconazole, is for patients who have been previously treated with fluconazole and have had either an insufficient response to treatment with fluconazole or a negative reaction to fluconazole preventing their further treatment with it.

Timeline

Start

2021-05-15

Primary completion

2022-09

Completion

2022-09

Outcome

Outcome not reported

Stopped: “Sponsor is not proceeding with study due to budget cuts as a result of COVID-19.”

Drugs

Indications